×
Sotera Health EBIT Margin 2019-2025 | SHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Sotera Health ebit margin from 2019 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
View More
Sotera Health EBIT Margin 2019-2025 | SHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Sotera Health ebit margin from 2019 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$136B
CVS Health (CVS)
$78.4B
Elevance Health (ELV)
$62.4B
Cencora (COR)
$56.8B
DiDi Global (DIDIY)
$26.9B
Labcorp Holdings (LH)
$20.4B
Natera (NTRA)
$19B
BioMerieux (BMXMF)
$16.9B
EUROFINS SCIENT (ERFSF)
$14B
CochLear (CHEOY)
$13.1B
Solventum (SOLV)
$12.7B
ICON (ICLR)
$11.6B
Revvity (RVTY)
$11B
Viatris (VTRS)
$10.4B
Avantor (AVTR)
$9.1B
Medpace Holdings (MEDP)
$9B
Sonic Healthcare (SKHHY)
$8.9B
HealthEquity (HQY)
$8.4B
Caris Life Sciences,�Inc (CAI)
$7.7B
Charles River Laboratories (CRL)
$7.6B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$4.9B
BrightSpring Health Services (BTSG)
$3.5B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.5B
Organon (OGN)
$2.5B
Alignment Healthcare (ALHC)
$2.5B
GeneDx Holdings (WGS)
$2.2B
Progyny (PGNY)
$1.9B
PACS (PACS)
$1.8B